NEW YORK, April 3 – Protein chip developer Zyomyx said Tuesday that Raju Kucherlapati has joined its board of directors.

Kucherlapati was a founder of Cell Genesys and Millennium Pharmaceuticals and currently serves as a director for Abgenix, Millennium, and Valentis.

Kucherlapati completed his postdoctoral work at Yale University and was awarded a PhD in genetics from the University of Illinois, Urbana.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.